Thursday, July 9, 2026

biotech · Ovarian Clear Cell Carcinoma · Tumors · LIXT

LIXTE BIOTECHNOLOGY HOLDINGS

LIXTE BIOTECHNOLOGY HOLDINGS trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

East Setauket, USA HQ
2006 Founded
7 Employees
Public company Type
LIXT · NYSE Ticker
Company details
Status
Public
HQ
East Setauket, USA
Founded
2006
Employees
7
Programs
3
Drugs
3
Patents
26
Intelligence · Clinical Trials

LIXTE BIOTECHNOLOGY HOLDINGS clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to LIXTE BIOTECHNOLOGY HOLDINGS programs — each row shows trial ID, program name, phase, status, and indication.

LIXTE BIOTECHNOLOGY HOLDINGS trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for LIXTE BIOTECHNOLOGY HOLDINGS.

  1. Dostarlimab — Phase 2

    Clinical update
  2. LB-100 for Injection — Phase 1

    Clinical update
  3. LB-100 — Phase 2

    Clinical update

Trial registry

3 studies